big pharma

  • Moneyball Could Offer Winning Strategy For Drug Development

    Moneyball Could Offer Winning Strategy For Drug Development

    Nearly one-third of drugs in development ultimately fail during clinical trials because the side effects are just too severe. Researchers at Cornell University have developed a promising new AI tool that better predicts which drug candidates are likely to be too toxic — and it’s based on the Oakland A’s winning strategy, immortalised in the…